Video

The Role of Potassium-Binding Agents in Treating Hyperkalemia

Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
RSV Respiratory syncytial virus vaccine vial on laboratory table with scientific research background - Image credit: AiDesign | stock.adobe.com
September 9th 2025

RSV Immunization Shows Cardiorespiratory Benefits in Adults Aged 60 and Older

Kennedy Ferruggia, Assistant Editor
Pharmacy focus oncology Edition, radon and lung cancer
September 9th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
radiology x-ray lung cancer - Image credit: utah51 | stock.adobe.com
September 9th 2025

FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC

Kennedy Ferruggia, Assistant Editor
Sifting Through Discordant Data From ESC 2025
September 9th 2025

Sifting Through Discordant Data From ESC 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
White pills in orange bottle with blood glucose meter on blue background with copy space - Image credit: neirfy | stock.adobe.com
September 9th 2025

Study Finds Greater Risk of Death From Type 2 Diabetes in Patients With Learning Disabilities

Kennedy Ferruggia, Assistant Editor
Wegovy injection pen | Image Credit: © Patrick Bay Damsted - stock.adobe.com
September 9th 2025

GLP-1s Reduce Risk of Hospitalization, Mortality by Over 40% in Patients With HFpEF

Alexandra Gerlach, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.